Stock Analysis of Catalyst Biosciences Inc (CBIO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code CBIO
Close 23.31
Change 22.80 / 4458.97 %
Volume 251660
Vol Change -209050.00 / 45.38 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Low Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Catalyst Biosciences Inc
PE (TTM)

-31082.94

Very Poor
Price / Book

47150.94

Very Poor
Price / Sales

-279746.42

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

885269 K

Enterprise Value

863641 K

ROA (TTM)

-35.53

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

900.00

Excellent
Revenue

89.18 %

794000
Net Profit

90.63 %

-8242.00 K
Debt to Equity

-0.0018

Very Poor
Altman Z Score

11.02

Excellent
Quick Ratio

0

Poor
Cash Ratio

1.29

Indecisive


Highs/Lows of Catalyst Biosciences Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.5113 4458.97 % 1.54 % 26.0321.530-Nov-2330-Nov-23
Two Week0.5113 4458.97 % 3.42 % 26.0321.530-Nov-2330-Nov-23
One Month0.5113 4458.97 % 5.60 % 26.0321.530-Nov-2330-Nov-23
Three Month0.5602 4061.01 % 5.95 % 26.030.3230-Nov-2313-Oct-23
Six Months0.2307 10004.03 % 17.48 % 26.030.2130-Nov-2301-Jun-23
One year0.5576 4080.42 % 27.52 % 26.030.1930-Nov-2329-Mar-23
Two year1.2 1842.50 % 29.70 % 26.030.1930-Nov-2329-Mar-23
Five year10.68 118.26 % 85.46 % 26.030.1930-Nov-2329-Mar-23
Ten year603.75 96.14 % 182.41 % 641.550.1916-Dec-1329-Mar-23


Technical View of Catalyst Biosciences Inc
RSI

99.25

Mild Bearish
MACD

1.83

Bullish
ADX

27.47

Mild Bullish
Super Trend

15.93

Mild Bullish
Williams %R

-10.58

Mild Bearish
CCI

666.67

Mild Bearish


EMA 5

8.11

Strong Bullish
EMA 15

3.33

Strong Bullish
EMA 50

1.36

Whipsaw
EMA 100

0.884

Mild Bullish
SMA 100

0.653

Whipsaw
SMA 200

0.443

Strong Bullish
SMA 5 / 20

5.08 / 1.59

Strong Bullish
SMA 15 / 50

1.98 / 0.952

Strong Bullish
SMA 50 / 200

0.952 / 0.443

Strong Bullish




Charts of Catalyst Biosciences Inc


Returns of Catalyst Biosciences Inc with Peers
Period / StockCBIOPLRXOPKRLAY
1 Week4458.97%10.57%3.13%3.43%
1 Mth4458.97%18.74%5.60%6.92%
3 Mth4061.01%-8.23%30.69%-38.75%
6mth10004.03%7.69%-7.69%-22.97%
1 Year4080.42%-29.08%-19.51%-35.91%
2 Year1842.50%210.37%-57.42%-63.62%
5 Years118.26%--35.61%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Catalyst Biosciences Inc with Peers
Ratio / StockCBIOPLRXOPKRLAY
PE-31082.94-2500.78-2.77-1849.14
P/B47150.94897.810.488766.55
ROA-35.53-32.79-12.17-35.84
ROE0-35.90-17.60-41.45
Debt To Equity-0.00180.02400.1890.0066
Revenue794000
89.18 % 		3545.00 K
63.40 % 		866931 K
13.67 % 		25800.00 K
1768.21 %
Net Income-8242.00 K
90.63 % 		-155287.00 K
25.92 % 		-207611.00 K
36.71 % 		-325981.00 K
12.21 %


Technicals of Catalyst Biosciences Inc with Peers
Technical / StockCBIOPLRXOPKRLAY-
ADX27.4723.6021.3428.84
CMF-0.219-0.00940.057-0.108
MFI89.1373.4270.2349.35
RSI99.2563.9457.8747.68
MACD Abv SignalTrueTrueFalseTrue
Price Above 50 MATrueTrueTrueFalse-
Price Above 200 MATrueFalseFalseFalse-


About : Catalyst Biosciences Inc

Address : 611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Tel : 650 871 0761
URL : https://www.catalystbiosciences.com
Code : CBIO, ISIN : US14888D2080, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 12_Apr_2006
Employee Count : 7

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)